Monday, November 30, 2009

EndoGastric Solutions Gains $21.5M

EndoGastric Solutions, a developer of treatments for gastroesophageal reflux disease (GERD) and other GI disorders which has facilities in Redmond, said late last week that it has raised $21.5M in a Series E financing. The firm said the funding was led by current investors. The company said that the round will go to expand its commercial presence. EndoGastric Solutions is backed by Advanced Technology Ventures, Chicago Growth Partners, Foundation Medical Partners,MPM Capital, Oakwood Medical Investors, and De Novo Ventures.